Cantor Fitzgerald resumed coverage on Forma Therapeutics with a new price target

6/13/22 7:18:38 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Cantor Fitzgerald resumed coverage of Forma Therapeutics with a rating of Overweight and set a new price target of $21.00 from $46.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$FMTX

Date	Price Target	Rating	Analyst
6/13/2022	$46.00 → $21.00	Overweight	Cantor Fitzgerald
11/12/2021	$54.00 → $40.00	Outperform	SVB Leerink
8/17/2021	$55.00 → $53.00	Buy	HC Wainwright & Co.
8/2/2021	$58.00	Buy	Craig Hallum